Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04994366 · ClinicalTrials.gov registry record

Increasing Patient Experience Survey Responses

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
929
Enrollment target

NCT04994366: Completed study, sponsored by NYU Langone Health.

NCT04994366 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 929 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04994366 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
929 participants
Enrollment target

Study Summary

This project aims to evaluate the effect of thank you cards on patient experience survey response rate.

Primary Outcome

The rate at which patients complete and submit the patient satisfaction survey

Interventions

  • OTHER Thank you card

Trial Details

FieldValue
Enrollment Target 929 participants
Start Date 2021-07-12
Est. Completion 2021-11-14
NYU Langone Health

1,164 total trials

What the finished NCT04994366 record still lists

NCT04994366 is an observational study that tracks outcomes without assigning an intervention. The registered 929 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Thank you card is the first listed.

NCT04994366 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04994366 about?

NCT04994366 is a clinical study titled "Increasing Patient Experience Survey Responses". This project aims to evaluate the effect of thank you cards on patient experience survey response rate.

What is the current status of trial NCT04994366?

This trial is currently completed. The enrollment target is 929 participants. The study started on 2021-07-12. Estimated completion is 2021-11-14.

What interventions are being tested in trial NCT04994366?

The interventions under investigation include: Thank you card (OTHER).

Who is sponsoring clinical trial NCT04994366?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06555029 · 929 participants · NA

    Oral Health Intervention in Adult Primary Care

  • NCT05216432 · 930 participants · Phase 1

    First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

  • NCT06932029 · 930 participants · NA

    SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases

  • NCT07235085 · 930 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04994366, the US trial registry maintained by the National Library of Medicine. NCT04994366 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.